167 related articles for article (PubMed ID: 23921991)
1. Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs.
Yu XQ; Clements M; O'Connell D
J Cancer Surviv; 2013 Dec; 7(4):641-51. PubMed ID: 23921991
[TBL] [Abstract][Full Text] [Related]
2. Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme.
Yip K; McConnell H; Alonzi R; Maher J
Br J Cancer; 2015 Apr; 112(9):1594-602. PubMed ID: 25791873
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer.
Yu XQ; De Angelis R; Luo Q; Kahn C; Houssami N; O'Connell DL
BMC Cancer; 2014 Dec; 14():936. PubMed ID: 25494610
[TBL] [Abstract][Full Text] [Related]
4. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
[TBL] [Abstract][Full Text] [Related]
5. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.
de Moor JS; Mariotto AB; Parry C; Alfano CM; Padgett L; Kent EE; Forsythe L; Scoppa S; Hachey M; Rowland JH
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):561-70. PubMed ID: 23535024
[TBL] [Abstract][Full Text] [Related]
6. Projecting cancer prevalence by phase of care: a methodological approach for health service planning.
Francisci S; Tursini F; Dal Maso L; Gigli A; Guzzinati S
Front Oncol; 2023; 13():1201464. PubMed ID: 37711195
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
8. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer prevalence in New South Wales Australia: a population-based study.
Yu XQ; Luo Q; Smith DP; Clements MS; O'Connell DL
Cancer Epidemiol; 2015 Feb; 39(1):29-36. PubMed ID: 25530551
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
13. A model for health projections using knowledgeable informants.
Levine A
World Health Stat Q; 1984; 37(3):306-17. PubMed ID: 6390992
[No Abstract] [Full Text] [Related]
14. The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care.
Sharp L; Deady S; Gallagher P; Molcho M; Pearce A; Alforque Thomas A; Timmons A; Comber H
BMC Cancer; 2014 Oct; 14():767. PubMed ID: 25319534
[TBL] [Abstract][Full Text] [Related]
15. Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study.
Yu XQ; Smith DP; Clements MS; Patel MI; McHugh B; O'Connell DL
BMJ Open; 2011 Apr; 1(1):e000104. PubMed ID: 22021763
[TBL] [Abstract][Full Text] [Related]
16. Categorising cancers to enable tailored care planning through a secondary analysis of cancer registration data in the UK.
McConnell H; White R; Maher J
BMJ Open; 2017 Nov; 7(11):e016797. PubMed ID: 29170285
[TBL] [Abstract][Full Text] [Related]
17. Cancer treatment and survivorship statistics, 2016.
Miller KD; Siegel RL; Lin CC; Mariotto AB; Kramer JL; Rowland JH; Stein KD; Alteri R; Jemal A
CA Cancer J Clin; 2016 Jul; 66(4):271-89. PubMed ID: 27253694
[TBL] [Abstract][Full Text] [Related]
18. How New Mexico Leveraged a COVID-19 Case Forecasting Model to Preemptively Address the Health Care Needs of the State: Quantitative Analysis.
Castro LA; Shelley CD; Osthus D; Michaud I; Mitchell J; Manore CA; Del Valle SY
JMIR Public Health Surveill; 2021 Jun; 7(6):e27888. PubMed ID: 34003763
[TBL] [Abstract][Full Text] [Related]
19. Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence.
Howell D; Hack TF; Oliver TK; Chulak T; Mayo S; Aubin M; Chasen M; Earle CC; Friedman AJ; Green E; Jones GW; Jones JM; Parkinson M; Payeur N; Sabiston CM; Sinclair S
J Cancer Surviv; 2012 Dec; 6(4):359-71. PubMed ID: 22777364
[TBL] [Abstract][Full Text] [Related]
20. The interface between primary and oncology specialty care: treatment through survivorship.
Grunfeld E; Earle CC
J Natl Cancer Inst Monogr; 2010; 2010(40):25-30. PubMed ID: 20386051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
